Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance (Q77386909)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9765002%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

review article

1 reference

title

Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9765002%20AND%20SRC:MED&resulttype=core&format=json

non-alcoholic steatohepatitis

5 December 2019

main subject

1 reference

O F James

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9765002%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

C P Day

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9765002%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9765002%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9765002%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9765002%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

495-501

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9765002%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9765002%20AND%20SRC:MED&resulttype=core&format=json

Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Clinical hepatology: profile of an urban, hospital-based practice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Fatty liver hepatitis and cirrhosis in obese patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Nonalcoholic steatohepatitis: a study of 49 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Fatty liver persisting for up to 33 years. A follow-up of the inversen-roholm liver biopsy material

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Nonalcoholic steatohepatitis: an expanded clinical entity.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

1 reference

7 January 2021

An epilogue to jejunoileal bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

A 13-year review of jejunoileal bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Idiopathic steatohepatitis in childhood: a multicenter retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Prognosis in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Paradoxical lack of ultrasound attenuation with gross fatty change in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Nonalcoholic steatohepatitis in obesity: a reversible condition

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Effect on Hepatic Morphology of Treatment of Obesity by Fasting, Reducing Diets and Small-Bowel Bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Persistent hyperaminotransferasemia resolving after weight reduction in obese children.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Two cases from the spectrum of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Liver transplantation for jejunoileal bypass-associated cirrhosis: allograft histology in the setting of an intact bypassed limb

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Experimental liver cirrhosis induced by alcohol and iron

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980073-1

7 January 2021

10.1016/S0168-8278(98)80073-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9765002%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference